Table 3.

Freedom from recurrence (FFR), freedom from local recurrence as the first site of failure (FFLR) and freedom from distant metastases as the first site of failure (FFDM) as a function of the combination of immunohistochemical score (IHC) and pathologic lymph node status at surgery.

Grouping Variable	n	5-yr FFR	5-yr FFLR	5-yr FFDM
IHC <30, Negative Lymph Nodes	37	76%	71%	95%
IHC ≥30, Negative Lymph Nodes	54	72%	77%	85%
IHC <30, Positive Lymph Nodes	8	50%	57%	70%
IHC ≥30, Positive Lymph Nodes	19	35%	61%	50%
P		0.0021	0.55	0.0004